Alpha 2.0
Login Register
» Articles » PMID: 35790882

Revisiting Checkpoint Blockade

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2022 Jul 5
PMID 35790882
Affiliations
Soon will be listed here.
Citing Articles

Cancer therapy with antibodies.

Paul S, Konig M, Pardoll D, Bettegowda C, Papadopoulos N, Wright K Nat Rev Cancer. 2024; 24(6):399-426.

PMID: 38740967 PMC: 11180426. DOI: 10.1038/s41568-024-00690-x.

IFN-γ lowers tumor growth by increasing glycolysis and lactate production in a nitric oxide-dependent manner: implications for cancer immunotherapy.

Chattopadhyay A, Jagdish S, Karhale A, Ramteke N, Zaib A, Nandi D Front Immunol. 2023; 14:1282653.

PMID: 37965321 PMC: 10641808. DOI: 10.3389/fimmu.2023.1282653.

Proof of concept nanotechnological approach to in vitro targeting of malignant melanoma for enhanced immune checkpoint inhibition.

Alharbi B, Qanash H, Binsaleh N, Alharthi S, Elasbali A, Gharekhan C Sci Rep. 2023; 13(1):7462.

PMID: 37156818 PMC: 10167246. DOI: 10.1038/s41598-023-34638-2.

Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities.

Brunell A, Lahesmaa R, Autio A, Thotakura A Front Immunol. 2023; 14:1151632.

PMID: 37122741 PMC: 10140554. DOI: 10.3389/fimmu.2023.1151632.

ICI efficacy information portal: a knowledgebase for responder prediction to immune checkpoint inhibitors.

Chen J, Rebibo D, Cao J, Mok S, Patel N, Tseng P NAR Cancer. 2023; 5(1):zcad012.

PMID: 36879684 PMC: 9984987. DOI: 10.1093/narcan/zcad012.